Equites Radar

CVS · CVS Health Corporation

Healthcare PlansUnited StatesAnalyst view: Strong Buy

$94.66

-0.66% last session

End-of-day data · close of 2026-09-11

Mildly bullish3 bullish · 1 bearish technical signals
Consensus: Strong Buy (1.44 from 25 analysts)
To mean target: +21.8%

Market cap

$122B

Enterprise value

$185B

Trailing P/E

25.2

Forward P/E

11.2

Dividend yield

3.0%

Beta

0.58

Avg volume

8M

Employees

219K

Daily Change %

-0.66%

5 Days Change

-1.41%

10 Days Change

1.57%

30 Days Change

2.01%

60 Days Change

-7.85%

Month to Day Change

-2.27%

Year to Day Change

23.00%

Analyst Outlook

Consensus ratingStrong Buy
Recommendation mean (1–5)1.44
Covering analysts25
Mean price target$116.04
Low price target$103.00
Upside to mean target+21.8%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)43.2
50-day MA$99.92
200-day MA$86.03
Price vs 50-day MA-5.3%
Price vs 200-day MA+10.0%
MACD histogram0.36
Volume vs 3-month avg0.6×
52w low $69.0452w high $109.92

Analyst sentiment over time — CVS

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-09-03

Latest call per bank · past 12 months

UBS

Buy

$118

+23.8% vs price
▼ cut from $126Maintains · 2026-09-03

JP Morgan

Overweight

$118

+23.8% vs price
▲ raised from $111Maintains · 2026-08-12

Barclays

Overweight

$108

+13.3% vs price
▲ raised from $106Maintains · 2026-08-06

Wells Fargo

Overweight

$123

+29.1% vs price
▲ raised from $103Maintains · 2026-07-13

RBC Capital

Outperform

$113

+18.6% vs price
▲ raised from $107Maintains · 2026-07-09

Bank of America

Buy

$110

+15.4% vs price
▲ raised from $100Maintains · 2026-06-23

Morgan Stanley

Overweight

$111

+16.5% vs price
▲ raised from $106Maintains · 2026-06-04

Goldman Sachs

Buy

$91.00

-4.5% vs price
▲ raised from $0.00Initiates · 2025-10-14

Recent rating actions

DateFirmActionRatingPrice target
2026-09-03UBSMaintainsBuy$126 $118
2026-08-19Argus ResearchMaintainsBuy$104 $114
2026-08-12JP MorganMaintainsOverweight$111 $118
2026-08-06UBSMaintainsBuy$122 $126
2026-08-06Evercore ISI GroupMaintainsOutperform$130 $125
2026-08-06BarclaysMaintainsOverweight$106 $108
2026-07-25UBSMaintainsBuy$115 $122
2026-07-14Truist SecuritiesMaintainsBuy$108 $118

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 43 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 5.3% below the 50-day MA ($99.92).
  • Price vs 200-day MA: Trading 10.0% above the 200-day MA ($86.03).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is positive (+0.36) — short-term momentum is improving.
  • 52-week range: Price sits between the 52-week low ($69.04) and high ($109.92).

CVS Price Chart

Loading chart for CVS

Fundamentals

Revenue (TTM)$413B
EBITDA$17B
Free cash flow$8.0B
Operating cash flow$15B
Book value / share$62.36
Net Debt / EBITDA3.7
WACC7.0%
Revenue growth7.00%
Earnings growth189.00%

About CVS Health Corporation

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

More in Healthcare Plans

Screen CVS against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.